Design
Review
Authors
Loading...
Alerts clinicians to postoperative immunosuppression risks in cancer patients; leaves open targeted immunomodulatory strategies for prospective trials.
Key points are not available for this paper at this time.
Dąbrowska et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: